You are here

Article Text

Article menu
Download PDFPDF
Short paper
Exhaled nitric oxide is reduced in infants with cystic fibrosis
  1. H E Elphicka,
  2. E A G Demoncheauxb,
  3. S Ritsona,
  4. T W Higenbottamb,
  5. M L Everarda
  1. aPediatric Respiratory Unit, Sheffield Children's Hospital, Sheffield S10 2TH, UK, bDivision of Clinical Sciences, Central Sheffield University Hospital Trust, University of Sheffield, UK
  1. Dr M L Everardm.l.everard{at}sheffield.ac.uk

Abstract

BACKGROUND Exhaled nitric oxide levels are low in patients with cystic fibrosis (CF), despite the chronic inflammation present in the airways. This study aimed to determine whether levels of exhaled nitric oxide were reduced prior to the onset of respiratory symptoms in infants with CF.

METHODS The levels of exhaled nitric oxide were measured using a chemiluminescence analyser in five infants with CF and 11 healthy control subjects, both groups having a mean age of 48.6 days.

RESULTS Mean levels of exhaled nitric oxide were significantly lower in infants with CF than in the control group (4.9 ppb v 12.1 ppb; p=0.01).

CONCLUSIONS This finding may be the key to understanding the inflammatory processes in early cystic fibrosis and may lead to novel treatment approaches.

  • cystic fibrosis
  • nitric oxide
  • paediatrics

https://doi.org/10.1136/thorax.56.2.151

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text